NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

The Horseracing Integrity and Safety Authority has announced an extension to the submission deadline for its request for ...

The submission deadline for HISA's furosemide request for proposals (RFP) has been extended to Nov. 22 from the original date of Oct. 15. The proposals should address furosemide's effects on horse ...

ELK GROVE VILLAGE, Ill., Oct. 21, 2024 /PRNewswire/ -- Orsini announced today that it has been chosen by scPharmaceuticals to distribute FUROSCIX® (furosemide injection) 80 mg/10mL for ...